Nuvation Bio (NUVB) News Today $2.80 +0.10 (+3.70%) (As of 11/22/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Nuvation Bio’s Q3 2024 Highlights and Future ProspectsNovember 21 at 5:33 AM | markets.businessinsider.comNuvation Bio (NYSE:NUVB) Shares Down 7.7% - Time to Sell?Nuvation Bio (NYSE:NUVB) Trading Down 7.7% - Should You Sell?November 15, 2024 | marketbeat.comNuvation Bio to Present at the Jefferies London Healthcare ConferenceNovember 12, 2024 | finance.yahoo.comNuvation Bio (NYSE:NUVB) Stock, Option ChainNovember 12, 2024 | benzinga.comWedbush Has Negative Outlook of Nuvation Bio FY2024 EarningsNuvation Bio Inc. (NYSE:NUVB - Free Report) - Investment analysts at Wedbush decreased their FY2024 earnings per share estimates for shares of Nuvation Bio in a research report issued on Thursday, November 7th. Wedbush analyst D. Nierengarten now forecasts that the company will post earnings of (November 11, 2024 | marketbeat.comNuvation Bio’s Global Challenges: Navigating Risks in China Amid Geopolitical TensionsNovember 8, 2024 | markets.businessinsider.comNuvation Bio (NYSE:NUVB) Shares Gap Up After Analyst UpgradeNuvation Bio (NYSE:NUVB) Shares Gap Up After Analyst UpgradeNovember 8, 2024 | marketbeat.comRoyal Bank of Canada Boosts Nuvation Bio (NYSE:NUVB) Price Target to $6.00Royal Bank of Canada raised their target price on shares of Nuvation Bio from $5.00 to $6.00 and gave the stock an "outperform" rating in a report on Thursday.November 7, 2024 | marketbeat.comNuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 6, 2024 | businesswire.comNuvation Bio Inc. (NUVB): Promising Penny Stock with Strong Oncology PipelineNovember 6, 2024 | msn.comNuvation Bio (NYSE:NUVB) Sees Unusually-High Trading Volume - Time to Buy?Nuvation Bio (NYSE:NUVB) Sees Strong Trading Volume - Should You Buy?October 30, 2024 | marketbeat.comNuvation Bio Inc. (NYSE:NUVB) Short Interest UpdateNuvation Bio Inc. (NYSE:NUVB - Get Free Report) was the recipient of a large drop in short interest during the month of October. As of October 15th, there was short interest totalling 9,970,000 shares, a drop of 53.5% from the September 30th total of 21,420,000 shares. Approximately 4.4% of the company's shares are short sold. Based on an average daily trading volume, of 1,520,000 shares, the short-interest ratio is currently 6.6 days.October 26, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Stock Price Down 4.3% - What's Next?Nuvation Bio (NYSE:NUVB) Stock Price Down 4.3% - What's Next?October 25, 2024 | marketbeat.comWedbush Has Positive Outlook for Nuvation Bio Q3 EarningsNuvation Bio Inc. (NYSE:NUVB - Free Report) - Investment analysts at Wedbush boosted their Q3 2024 EPS estimates for shares of Nuvation Bio in a research note issued on Tuesday, October 22nd. Wedbush analyst D. Nierengarten now forecasts that the company will earn ($0.12) per share for the quarteOctober 24, 2024 | marketbeat.comFY2028 Earnings Forecast for Nuvation Bio Issued By WedbushNuvation Bio Inc. (NYSE:NUVB - Free Report) - Wedbush issued their FY2028 earnings estimates for shares of Nuvation Bio in a report issued on Tuesday, October 22nd. Wedbush analyst D. Nierengarten anticipates that the company will earn ($0.01) per share for the year. Wedbush has a "Outperform" rOctober 23, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Receives "Outperform" Rating from WedbushWedbush reaffirmed an "outperform" rating and set a $5.00 price target on shares of Nuvation Bio in a research note on Tuesday.October 22, 2024 | marketbeat.comNuvation Bio: Competitive Data In ROS1+ NSCLC, Strong Cash, Smallish MarketOctober 21, 2024 | seekingalpha.comNuvation Bio (NYSE:NUVB) Stock Price Down 5.8% - Time to Sell?Nuvation Bio (NYSE:NUVB) Shares Down 5.8% - What's Next?October 17, 2024 | marketbeat.comIs Nuvation Bio Inc. (NUVB) the Hottest Penny Stock to Invest in According to Hedge Funds?October 16, 2024 | msn.comRobert Mashal At Nuvation Bio Tops Up Holding By US$220kOctober 16, 2024 | finance.yahoo.comIs Nuvation Bio Inc. (NUVB) Hedge Funds’ Favorite Penny Stock?October 15, 2024 | msn.comNuvation Bio (NYSE:NUVB) Stock Price Up 10.4% Following Insider Buying ActivityNuvation Bio (NYSE:NUVB) Stock Price Up 10.4% Following Insider Buying ActivityOctober 11, 2024 | marketbeat.comInsider Buying: Nuvation Bio Inc. (NYSE:NUVB) Director Purchases 100,000 Shares of StockOctober 11, 2024 | insidertrades.comNuvation Bio Inc. (NYSE:NUVB) Shares Purchased by Dimensional Fund Advisors LPDimensional Fund Advisors LP raised its stake in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 415.2% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,018,329 shares of the company's stock after acquiringOctober 11, 2024 | marketbeat.comInsider Buying: Nuvation Bio Inc. (NYSE:NUVB) Director Acquires 100,000 Shares of StockNuvation Bio Inc. (NYSE:NUVB - Get Free Report) Director Robert Mashal purchased 100,000 shares of the company's stock in a transaction that occurred on Tuesday, October 8th. The shares were purchased at an average price of $2.20 per share, for a total transaction of $220,000.00. Following the transaction, the director now owns 100,000 shares of the company's stock, valued at $220,000. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.October 10, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Stock Price Down 5.4% - Here's What HappenedNuvation Bio (NYSE:NUVB) Shares Down 5.4% - What's Next?October 10, 2024 | marketbeat.comGrowing Confidence in Nuvation Bio, Inc. (NUVB) as Hedge Fund Holdings Increase to 35October 9, 2024 | msn.comNuvation Bio Names Philippe Sauvage Chief Financial OfficerOctober 7, 2024 | marketwatch.comNuvation Bio Appoints Industry Veteran Philippe Sauvage as Chief Financial OfficerOctober 7, 2024 | businesswire.comAlgert Global LLC Acquires 314,635 Shares of Nuvation Bio Inc. (NYSE:NUVB)Algert Global LLC lifted its holdings in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 281.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 426,603 shares of the company's stock after acquiring an additionaOctober 5, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comNuvation Bio (NYSE:NUVB) Shares Up 4.1%Nuvation Bio (NYSE:NUVB) Shares Up 4.1%October 3, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Shares Down 4.3% Nuvation Bio (NYSE:NUVB) Stock Price Down 4.3%October 2, 2024 | marketbeat.comNavigating Legal Uncertainty: Nuvation Bio Inc.’s Chinese Operations and the Shifting Landscape of China’s Civil Law SystemOctober 2, 2024 | finance.yahoo.comBioAge Labs Inc.September 28, 2024 | money.usnews.comNuvation Bio (NYSE:NUVB) Trading Down 2.6%Nuvation Bio (NYSE:NUVB) Shares Down 2.6%September 18, 2024 | marketbeat.comEquities Analysts Issue Forecasts for Nuvation Bio Inc.'s Q3 2024 Earnings (NYSE:NUVB)Nuvation Bio Inc. (NYSE:NUVB - Free Report) - Research analysts at HC Wainwright decreased their Q3 2024 EPS estimates for shares of Nuvation Bio in a research note issued on Monday, September 16th. HC Wainwright analyst R. Burns now anticipates that the company will post earnings per share of ($September 18, 2024 | marketbeat.comJefferies Releases a Buy Rating on Nuvation Bio (NUVB)September 16, 2024 | markets.businessinsider.comPositive Pooled Data from Nuvation Bio’s TRUST-I and TRUST-II Studies Highlight Taletrectinib’s Best-in-Class Potential for Patients with Advanced ROS1-positive NSCLC ...September 15, 2024 | businesswire.comAcadian Asset Management LLC Has $1.91 Million Position in Nuvation Bio Inc. (NYSE:NUVB)Acadian Asset Management LLC lessened its stake in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 44.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 653,184 shares of the company's stock after selling 521,280 shares durinSeptember 15, 2024 | marketbeat.comPositive Pooled Data from Nuvation Bio's TRUST-I and TRUST-II Studies Highlight Taletrectinib's Best-in-Class Potential for Patients with Advanced ROS1-positive NSCLC, Supporting Planned New Drug Application Submission in the Fourth Quarter of 2024September 14, 2024 | businesswire.comStrong Buy Recommendation for Nuvation Bio Based on Superior Clinical Data and Market ValuationSeptember 12, 2024 | markets.businessinsider.comNuvation Bio (NUVB) Receives a Buy from WedbushSeptember 12, 2024 | markets.businessinsider.comNuvation Bio (NYSE:NUVB) Given Outperform Rating at WedbushWedbush reaffirmed an "outperform" rating and issued a $5.00 price objective on shares of Nuvation Bio in a report on Wednesday.September 11, 2024 | marketbeat.comNuvation Bio to Present at the Cantor Global Healthcare ConferenceSeptember 9, 2024 | finance.yahoo.comNuvation Bio (NYSE:NUVB) Trading 8.6% Higher Nuvation Bio (NYSE:NUVB) Trading 8.6% HigherSeptember 9, 2024 | marketbeat.comPanagora Asset Management Inc. Buys 421,563 Shares of Nuvation Bio Inc. (NYSE:NUVB)Panagora Asset Management Inc. grew its stake in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 198.7% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 633,676 shares of the company's stock after buying an additioSeptember 1, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Trading 4.5% Higher Nuvation Bio (NYSE:NUVB) Stock Price Up 4.5%August 26, 2024 | marketbeat.comWith 47% stake, Nuvation Bio Inc. (NYSE:NUVB) seems to have captured institutional investors' interestAugust 22, 2024 | finance.yahoo.comNuvation Bio (NYSE:NUVB) Trading Down 3.1%Nuvation Bio (NYSE:NUVB) Trading Down 3.1%August 21, 2024 | marketbeat.com Get Nuvation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter. Email Address 2024 Election Year Stocks: Uncover Hidden Gems! (Ad)In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss. Secure your copy now by clicking this link. NUVB Media Mentions By Week NUVB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NUVB News Sentiment▼0.150.49▲Average Medical News Sentiment NUVB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NUVB Articles This Week▼13▲NUVB Articles Average Week Get Nuvation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ImmunityBio News Apellis Pharmaceuticals News MoonLake Immunotherapeutics News PTC Therapeutics News Agios Pharmaceuticals News HUTCHMED News Merus News Xenon Pharmaceuticals News Edgewise Therapeutics News Verona Pharma News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NUVB) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvation Bio Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvation Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NUVB Stock Alerts